Two-Drug cocktail shows promise for awakening traumatic brain injury patients
NCT ID NCT06052787
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether adding two drugs—cerebrolysin and amantadine sulfate—to standard care helps people with moderate to severe traumatic brain injury recover in the ICU. 150 adults aged 18-70 took part. Researchers measured consciousness, disability, and recovery over 6 weeks. The goal was to see if the combination improves outcomes more than standard treatment alone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRAUMATIC BRAIN INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of medicine - Ain shams university
Cairo, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal zaps could reboot breathing after brain injury
- Could music be medicine for the injured brain?
- Can blood markers predict brain injury outcomes?
- Can a treadmill that adapts to your pace fix uneven steps?
- Can brain training help TBI patients remember to remember?
- Can a natural protein fragment help the brain heal after severe injury?